Evaluation of nine commercial SARS-CoV-2 immunoassays
Detection Principle
ImmunoAssay-Antibody
Target
IgM/IgG, IgA on S1-domain, RBD-domain of S-protein
Testing Method Category
Testing Method
Multiple-kits
Testing Method - Additional Info
8 different kits
Reported Performance
Sensitivity: 93% (Wantai Total Ab ELISA), 93% ( Euroimmun IgA), 67% (IgG ELISAs), 90% (Dynamiker), 90% (CTK Biotech), 93% (AutoBio Diagnostics), 83% (Artron Laboratories), 80% (Acro Biotech), 100% (Alltest Biotech) ; Specificity: 100% (Wantai Total Ab ELISA), 93% ( Euroimmun IgA), 96% (IgG ELISAs), 100% (Dynamiker), 100% (CTK Biotech), 100% (AutoBio Diagnostics), 100% (Artron Laboratories), 80% (Acro Biotech), 87% (Alltest Biotech)
Sample Size
112 negative
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements